Qing Yi, M.D., Ph.D.
Qing Yi, M.D., Ph.D.
The Methodist Hospital Research Institute
Titles & Positions

  • Associate Director, Basic Research, Houston Methodist Cancer Center

  • Director, Houston Methodist Center for Translational Research in Hematological Malignancies

Institutional & Related Links



Grant Information

Grant ID: RR180044
Grant Mechanism: 
Recruitment of Established Investigators
Recruited From: 
Lerner Research Institute - Cleveland Clinic
Date Awarded: 
May 16, 2018
Grant Amount: 

Multiple myeloma is the second-most common blood cancer after non-Hodgkins lymphoma. Although it boasts a five-year survival rate of 50%, most patients eventually die from relapse of the disease.

Now a researcher at Houston Methodist Research Institute is trying to develop immune therapy for multiple myeloma that might provide patients with a better choice of treatment for their disease.        

Dr. Qing Yi, who chaired the department of cancer biology at the Cleveland Clinic Lerner Research Institute, returns to Texas as Associate Director of the Houston Methodist Research Institute and Director of the Research Center for Hematologic Malignancies. He was recruited with the help of an Established Investigator Award from CPRIT. Dr. Yi was formerly a tenured professor of medicine at The University of Texas MD Anderson Cancer Center.

Read More